On November 12, Rocket Lab USA, Inc. fell 4.01% in After-Hours Trading, trading at $63.8 per share, with turnover of $96.4993 million.
The move followed continued market digestion of a lower analyst price target alongside the company’s recent Q3 results and proposed roughly $8 billion acquisition of Iridium Communications.
Recent coverage indicated Morgan Stanley lowered its price target to $103 from $105 while maintaining an Overweight rating, and Needham also reduced its target to $100. Earlier disclosures showed Q3 revenue rose 73% year over year to $267.8 million, above expectations, but per-share loss widened to $0.12 versus expectations for a smaller loss, while long-term optimism around Neutron commercialization was described as outweighing near-term margin noise.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments